Results 131 to 140 of about 2,357,761 (180)

Case Report: Radical nephroureterectomy after toripalimab plus disitamab vedotin in biomarker-non-enriched upper tract urothelial carcinoma. [PDF]

Front Oncol
Cheng G, Zhang Q, Li R, Zhou Z, Kong X, Dong Z.   +5 more
europepmc   +1 more source

Radical surgery for upper tract urothelial carcinoma

, 2018
Madaan, S., Reekhaye, A.
core  

Circulating Tumor DNA in Upper Tract Urothelial Carcinoma: A Framework for Precision Perioperative Management. [PDF]

Cancers (Basel)
Prakash A, Cherico A, Ayanambakkam A, Polimera HV.   +3 more
europepmc   +1 more source

Immunohistochemistry-based risk stratification of upper tract urothelial carcinoma. [PDF]

Front Oncol
He DL, Zi GR, Zhang DJ, Zhong HQ, Wang C, Feng RL, Ke CX.   +6 more
europepmc   +1 more source

Management of Upper Tract Urothelial Carcinoma

Advances in Urology, 2009
Norm D. Smith
doaj   +1 more source

Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma. [PDF]

Front Oncol
Zhang Y, Shen S, Li W, Hu Y, Zhang Y, Li K, Wang G.   +6 more
europepmc   +1 more source

Differentiating Upper Tract Urothelial Carcinoma with Synchronous or Metachronous Bladder Cancer. [PDF]

Curr Issues Mol Biol
Meireles S, Dias C, Marques A, Silva J, Costa L, Lopes JM, Soares P.   +6 more
europepmc   +1 more source

SOX2-positive upper tract urothelial carcinoma: Clinicopathological characteristics and therapeutic implications. [PDF]

Oncol Lett
Yasukawa H, Ikehata Y, Nishiyama N, Kitamura H.   +3 more
europepmc   +1 more source

Neoadjuvant chemotherapy in upper tract urothelial carcinoma: interpreting durable long-term outcomes in a changing treatment landscape. [PDF]

Transl Androl Urol
Palanjian RR, Mallick S, Eskenazi F, Dugarte JP, Nigam S, Sayyid RK.   +5 more
europepmc   +1 more source